Teleflex (TFX) Revenue & Revenue Breakdown
Teleflex Revenue Highlights
Latest Revenue (Y)
$2.97B
Latest Revenue (Q)
$749.69M
Main Segment (Y)
Vascular Access
Main Geography (Y)
Americas Segment
Teleflex Revenue by Period
Teleflex Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2023-12-31 | $2.97B | 6.57% |
| 2022-12-31 | $2.79B | -0.66% |
| 2021-12-31 | $2.81B | 10.74% |
| 2020-12-31 | $2.54B | -2.24% |
| 2019-12-31 | $2.60B | 6.00% |
| 2018-12-31 | $2.45B | 14.07% |
| 2017-12-31 | $2.15B | 14.90% |
| 2016-12-31 | $1.87B | 3.22% |
| 2015-12-31 | $1.81B | -1.64% |
| 2014-12-31 | $1.84B | 8.46% |
| 2013-12-31 | $1.70B | 9.37% |
| 2012-12-31 | $1.55B | 1.45% |
| 2011-12-31 | $1.53B | -15.14% |
| 2010-12-31 | $1.80B | -4.67% |
| 2009-12-31 | $1.89B | -21.93% |
| 2008-12-31 | $2.42B | 25.16% |
| 2007-12-31 | $1.93B | -26.92% |
| 2006-12-31 | $2.65B | 5.26% |
| 2005-12-25 | $2.51B | 1.17% |
| 2004-12-26 | $2.49B | 8.89% |
| 2003-12-28 | $2.28B | 9.93% |
| 2002-12-29 | $2.08B | 8.99% |
| 2001-12-31 | $1.91B | 7.96% |
| 2000-12-31 | $1.76B | 10.20% |
| 1999-12-26 | $1.60B | 11.37% |
| 1998-12-27 | $1.44B | 25.47% |
| 1997-12-28 | $1.15B | 23.05% |
| 1996-12-29 | $931.20M | 2.03% |
| 1995-12-31 | $912.70M | 12.30% |
| 1994-12-25 | $812.70M | 21.88% |
| 1993-12-26 | $666.80M | - |
Teleflex generated $2.97B in revenue during NA 2023, up 6.57% compared to the previous quarter, and up 121.49% compared to the same period a year ago.
Teleflex Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2024-06-30 | $749.69M | 1.60% |
| 2024-03-31 | $737.85M | -4.66% |
| 2023-12-31 | $773.91M | 3.69% |
| 2023-10-01 | $746.39M | 0.42% |
| 2023-07-02 | $743.26M | 4.55% |
| 2023-04-02 | $710.93M | -6.21% |
| 2022-12-31 | $758.00M | 10.37% |
| 2022-09-25 | $686.79M | -2.52% |
| 2022-06-26 | $704.54M | 9.79% |
| 2022-03-27 | $641.72M | -15.78% |
| 2021-12-31 | $761.91M | 8.81% |
| 2021-09-26 | $700.25M | -1.85% |
| 2021-06-27 | $713.47M | 12.55% |
| 2021-03-28 | $633.92M | -10.86% |
| 2020-12-31 | $711.18M | 13.19% |
| 2020-09-27 | $628.30M | 10.80% |
| 2020-06-28 | $567.03M | -10.09% |
| 2020-03-29 | $630.64M | -7.39% |
| 2019-12-31 | $680.95M | 5.03% |
| 2019-09-29 | $648.32M | -0.64% |
| 2019-06-30 | $652.51M | 6.34% |
| 2019-03-31 | $613.58M | -4.37% |
| 2018-12-31 | $641.62M | 5.24% |
| 2018-09-30 | $609.67M | -0.03% |
| 2018-07-01 | $609.87M | 3.85% |
| 2018-04-01 | $587.23M | -1.32% |
| 2017-12-31 | $595.11M | 11.30% |
| 2017-10-01 | $534.70M | 1.15% |
| 2017-07-02 | $528.61M | 8.35% |
| 2017-04-02 | $487.88M | -5.07% |
| 2016-12-31 | $513.93M | 12.79% |
| 2016-09-25 | $455.65M | -3.78% |
| 2016-06-26 | $473.55M | 11.45% |
| 2016-03-27 | $424.89M | -12.30% |
| 2015-12-31 | $484.50M | 9.19% |
| 2015-09-27 | $443.71M | -1.84% |
| 2015-06-28 | $452.05M | 5.27% |
| 2015-03-29 | $429.43M | -9.79% |
| 2014-12-31 | $476.01M | 4.12% |
| 2014-09-28 | $457.17M | -2.34% |
| 2014-06-29 | $468.11M | 6.74% |
| 2014-03-30 | $438.55M | -2.66% |
| 2013-12-31 | $450.54M | 8.88% |
| 2013-09-29 | $413.80M | -1.49% |
| 2013-06-30 | $420.06M | 1.99% |
| 2013-03-31 | $411.88M | -1.71% |
| 2012-12-31 | $419.06M | 13.86% |
| 2012-09-30 | $368.05M | -3.99% |
| 2012-07-01 | $383.33M | -1.14% |
| 2012-04-01 | $387.76M | -5.82% |
| 2011-12-31 | $411.73M | 10.71% |
| 2011-09-25 | $371.89M | -4.96% |
| 2011-06-26 | $391.29M | 0.68% |
| 2011-03-27 | $388.66M | -18.32% |
| 2010-12-31 | $475.84M | 7.41% |
| 2010-09-26 | $442.99M | -4.05% |
| 2010-06-27 | $461.68M | 5.78% |
| 2010-03-28 | $436.46M | -15.25% |
| 2009-12-31 | $515.00M | 11.60% |
| 2009-09-27 | $461.48M | -4.47% |
| 2009-06-28 | $483.06M | 2.85% |
| 2009-03-29 | $469.68M | -21.26% |
| 2008-12-31 | $596.46M | 0.10% |
| 2008-09-28 | $595.88M | -4.52% |
| 2008-06-29 | $624.09M | 3.24% |
| 2008-03-30 | $604.52M | -978.76% |
| 2007-12-31 | $-68.79M | - |
Teleflex generated $749.69M in revenue during Q2 2024, up 1.60% compared to the previous quarter, and up 105.45% compared to the same period a year ago.
Teleflex Revenue Breakdown
Teleflex Revenue Breakdown by Product
Annual Revenue by Product
| Product/Service | Dec 23 | Dec 22 | Dec 21 | Dec 20 | Dec 19 |
|---|---|---|---|---|---|
| Anesthesia | $389.96M | $388.89M | $380.14M | $302.29M | $338.41M |
| Surgical | $427.36M | $392.92M | $377.76M | $317.20M | $370.07M |
| Vascular Access | $708.04M | $683.61M | $700.24M | $657.70M | $600.87M |
| Other | $291.90M | $285.15M | $336.58M | $367.26M | $347.27M |
| Interventional | $511.43M | $445.02M | $427.50M | $382.44M | $427.56M |
| Interventional Urology | $319.79M | $322.83M | $341.66M | $290.02M | $290.45M |
| Oem | - | $272.62M | $245.68M | $220.25M | $220.72M |
Teleflex's latest annual revenue breakdown by segment (product or service), as of Dec 23: Vascular Access (26.73%), Interventional (19.31%), Surgical (16.14%), Anesthesia (14.72%), Interventional Urology (12.07%), and Other (11.02%).
Quarterly Revenue by Product
| Product/Service | Jun 24 | Mar 24 | Dec 23 | Oct 23 | Jul 23 | Apr 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Surgical | $111.30M | $105.52M | $109.58M | $112.81M | $105.95M | $99.02M | $110.45M | $93.12M | $99.64M | $89.70M | $106.35M | $92.83M | $98.19M | $80.39M | $92.27M | $82.22M | $67.28M | $75.43M | $95.16M | $92.62M |
| Vascular Access | $181.10M | $181.35M | $186.69M | $169.92M | $173.78M | $177.65M | $186.42M | $167.15M | $163.91M | $166.13M | $193.05M | $175.48M | $167.74M | $163.97M | $182.45M | $160.05M | $164.96M | $150.26M | $154.65M | $148.68M |
| Other | $41.70M | $52.52M | $68.26M | $76.03M | $75.95M | $71.65M | $73.59M | $69.91M | $72.14M | $69.51M | $84.68M | $83.38M | $86.84M | $81.68M | $98.10M | $86.02M | $91.41M | $91.74M | $89.37M | $83.94M |
| Interventional | $141.16M | $134.66M | $135.67M | $134.09M | $124.78M | $116.90M | $125.08M | $108.74M | $114.34M | $96.86M | $114.94M | $104.30M | $112.08M | $96.17M | $106.73M | $93.19M | $82.59M | $99.93M | $112.71M | $106.88M |
| Interventional Urology | $83.10M | $79.74M | $92.97M | $73.62M | $77.82M | $75.38M | $89.15M | $78.97M | $79.82M | $74.89M | $92.95M | $83.11M | $92.24M | $73.36M | $93.91M | $81.77M | $40.09M | $74.19M | $89.14M | $73.63M |
| Anesthesia | $102.49M | $96.35M | $98.17M | $97.61M | $100.84M | $93.33M | $99.63M | $97.61M | $104.69M | $86.96M | $102.78M | $97.07M | $95.43M | $84.86M | $86.09M | $75.65M | $64.87M | $75.70M | $85.31M | $87.12M |
| Oem | - | $87.70M | $82.31M | $84.13M | $77.00M | $73.68M | $71.29M | $70.00M | $57.66M | $67.15M | $64.08M | $60.96M | $53.49M | $51.63M | $63.39M | - | - | - | - | - |
Teleflex's latest quarterly revenue breakdown by segment (product or service), as of Jun 24: Vascular Access (27.40%), Interventional (21.36%), Surgical (16.84%), Anesthesia (15.51%), Interventional Urology (12.58%), and Other (6.31%).
Teleflex Revenue Breakdown by Country
Annual Revenue by Country
| Country | Dec 23 | Dec 22 | Dec 21 | Dec 20 | Dec 19 |
|---|---|---|---|---|---|
| EMEA Segment | $586.25M | - | - | - | - |
| Oem | $326.01M | - | - | - | - |
| Americas Segment | $1.72B | - | - | - | - |
| Asia Segment | $346.90M | - | - | - | - |
| Europe | - | $622.34M | $665.00M | $646.58M | $652.07M |
| All Other | - | $111.48M | $112.05M | $93.17M | $95.77M |
| UNITED STATES | - | $1.79B | $1.77B | $1.57B | $1.61B |
| Asia And Asia Pacific | - | $270.75M | $263.02M | $230.27M | $241.28M |
Teleflex's latest annual revenue breakdown by geography, as of Dec 23: Americas Segment (57.67%), EMEA Segment (19.71%), Asia Segment (11.66%), and Oem (10.96%).
Quarterly Revenue by Country
| Country | Jun 24 | Mar 24 | Dec 23 | Oct 23 | Jul 23 | Apr 23 | Sep 22 | Jun 22 | Mar 22 | Sep 21 | Jun 21 | Mar 21 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | Jun 19 | Mar 19 | Dec 18 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EMEA | $147.06M | $159.66M | $135.65M | $131.64M | $156.12M | $145.93M | $140.52M | $147.05M | $154.54M | - | - | - | - | - | - | - | - | - | - | - |
| Americas Segment | $426.81M | $406.29M | $450.62M | $428.21M | $424.64M | $411.86M | $405.04M | $412.74M | $377.96M | $417.33M | $414.79M | $375.49M | - | - | - | - | - | - | - | - |
| Asia | $87.00M | $84.21M | $68.21M | $67.07M | $53.13M | $80.46M | $77.86M | $75.23M | $60.78M | - | - | - | - | - | - | - | - | - | - | - |
| Oem | $88.83M | $87.70M | $49.40M | $55.83M | $63.39M | $54.61M | $55.44M | $56.43M | $54.24M | - | - | - | - | - | - | - | - | - | - | - |
| OEM Segment | - | $87.70M | $82.31M | $84.13M | $77.00M | $71.29M | $70.00M | $57.66M | $64.08M | $60.96M | $53.49M | - | - | - | - | - | - | - | - | - |
| EMEA Segment | - | $159.66M | $152.37M | $142.72M | $147.81M | $143.34M | $128.44M | $145.19M | $136.91M | $143.88M | $157.13M | $141.25M | - | - | - | - | - | - | - | - |
| Asia Segment | - | $84.21M | $88.34M | $93.15M | $86.68M | $78.73M | $82.03M | $76.61M | $69.19M | $74.96M | $80.60M | $63.69M | - | - | - | - | - | - | - | - |
| Vascular North America | - | - | - | - | - | - | - | - | - | - | - | - | $375.04M | $312.49M | $358.00M | $399.95M | $374.49M | $373.80M | $344.02M | - |
| All Other | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $24.09M |
| Europe | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $-266.61M |
| UNITED STATES | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $383.33M |
Teleflex's latest quarterly revenue breakdown by geography, as of Jun 24: Americas Segment (56.93%), EMEA (19.62%), Oem (11.85%), and Asia (11.60%).
Teleflex Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| BDX | Becton, Dickinson and Company | $19.37B | $4.99B |
| ALC | Alcon | $10.09B | $2.46B |
| RMD | ResMed | $4.69B | $1.20B |
| HOLX | Hologic | $4.03B | $1.01B |
| COO | Cooper Companies | $3.59B | $1.00B |
| ATR | AptarGroup | $3.49B | $910.06M |
| TFX | Teleflex | $2.97B | $749.69M |
| WST | West Pharmaceutical Services | $2.95B | $702.00M |
| NVST | Envista | $2.57B | $623.60M |
| ICUI | ICU Medical | $2.26B | $596.46M |
| HAE | Haemonetics | $1.31B | $336.17M |
| MMSI | Merit Medical Systems | $1.26B | $338.00M |
| ANGO | AngioDynamics | $303.91M | $75.18M |
TFX Revenue FAQ
What is Teleflex’s yearly revenue?
Teleflex's yearly revenue for 2023 was $2.97B, representing an increase of 6.57% compared to 2022. The company's yearly revenue for 2022 was $2.79B, representing a decrease of -0.66% compared to 2021. TFX's yearly revenue for 2021 was $2.81B, representing an increase of 10.74% compared to 2020.
What is Teleflex’s quarterly revenue?
Teleflex's quarterly revenue for Q2 2024 was $749.69M, a 1.60% increase from the previous quarter (Q1 2024), and a 0.87% increase year-over-year (Q2 2023). The company's quarterly revenue for Q1 2024 was $737.85M, a -4.66% decrease from the previous quarter (Q4 2023), and a 3.79% increase year-over-year (Q1 2023). TFX's quarterly revenue for Q4 2023 was $773.91M, a 3.69% increase from the previous quarter (Q3 2023), and a 2.10% increase year-over-year (Q4 2022).
What is Teleflex’s revenue growth rate?
Teleflex's revenue growth rate for the last 3 years (2021-2023) was 5.87%, and for the last 5 years (2019-2023) was 14.61%.
What are Teleflex’s revenue streams?
Teleflex's revenue streams in c 23 are Anesthesia, Surgical, Vascular Access, Other, Interventional, and Interventional Urology. Anesthesia generated $389.96M in revenue, accounting 14.72% of the company's total revenue, up 0.27% year-over-year. Surgical generated $427.36M in revenue, accounting 16.14% of the company's total revenue, up 8.77% year-over-year. Vascular Access generated $708.04M in revenue, accounting 26.73% of the company's total revenue, up 3.57% year-over-year. Other generated $291.9M in revenue, accounting 11.02% of the company's total revenue, up 2.37% year-over-year. Interventional generated $511.43M in revenue, accounting 19.31% of the company's total revenue, up 14.92% year-over-year. Interventional Urology generated $319.78M in revenue, accounting 12.07% of the company's total revenue, down -0.94% year-over-year.
What is Teleflex’s main source of revenue?
For the fiscal year ending Dec 23, the largest source of revenue of Teleflex was Vascular Access. This segment made a revenue of $708.04M, representing 26.73% of the company's total revenue.